Evidence map›Paper›PMID 37072639›Full record

ArticleSurgical endoscopy2023

Practice variation and outcomes of minimally invasive minor liver resections in patients with colorectal liver metastases: a population-based study.

Michelle R de Graaff, Joost M Klaase, Ruben de Kleine, Arthur K E Elfrink, Rutger-Jan Swijnenburg, Babs M Zonderhuis, J Sven D Mieog, Wouter J M Derksen, Jeroen Hagendoorn, Peter B van den Boezem and 18 more

Abstract read
In one paragraph

Article in Surgical endoscopy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Michelle R de GraaffDutch Institute for Clinical Auditing, Scientific Bureau, 2333 AA, Leiden, The Netherlands. m.r.de.graaff@umcg.nl.ORCID http://orcid.org/0000-0002-5957-5824
Joost M KlaaseDepartment of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Medical Centre Groningen, Groningen, The Netherlands.
Ruben de KleineDepartment of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Medical Centre Groningen, Groningen, The Netherlands.
Arthur K E ElfrinkDepartment of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Rutger-Jan SwijnenburgDepartment of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Babs M ZonderhuisDepartment of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
J Sven D MieogDepartment of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
Wouter J M DerksenDepartment of Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands.
Jeroen HagendoornDepartment of Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands.
Peter B van den BoezemDepartment of Surgery, Radboud Medical Centre, Nijmegen, The Netherlands.
Arjen M RijkenDepartment of Surgery, Amphia Medical Centre, Breda, The Netherlands.
Paul D GobardhanDepartment of Surgery, Amphia Medical Centre, Breda, The Netherlands.
Hendrik A MarsmanDepartment of Surgery, OLVG, Amsterdam, The Netherlands.
Mike S L LiemDepartment of Surgery, Medical Spectrum Twente, Enschede, The Netherlands.
Wouter K G LeclercqDepartment of Surgery, Máxima Medical Centre, Veldhoven, The Netherlands.
Tjarda N T van HeekDepartment of Surgery, Gelderse Vallei, Ede, The Netherlands.
Gijs A PantijnDepartment of Surgery, Isala, Zwolle, The Netherlands.
Koop BosschaDepartment of Surgery, Jeroen Bosch Hospital, 's Hertogenbosch, The Netherlands.
Eric J T BeltDepartment of Surgery, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Maarten VermaasDepartment of Surgery, Ijsselland Hospital, Capelle Aan de Ijssel, The Netherlands.
Hans TorrengaDepartment of Surgery, Deventer Hospital, Deventer, The Netherlands.
Eric R ManusamaDepartment of Surgery, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
Petrousjka van den TolDepartment of Surgery, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
Steven J OosterlingDepartment of Surgery, Spaarne Gasthuis, Haarlem/Hoofddorp, The Netherlands.
Marcel den DulkDepartment of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
Dirk J Grünhagen *Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Niels F M Kok *Department of Surgery, Antoni van Leeuwenhoek - Dutch Cancer Institute, Amsterdam, The Netherlands.
For Dutch Hepato Biliary Audit Group, Collaborators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn 2017, the Southampton guideline stated that minimally invasive liver resections (MILR) should considered standard practice for minor liver resections. This study aimed to assess recent implementation rates of minor MILR, factors associated with performing MILR, hospital variation, and outcomes in patients with colorectal liver metastases (CRLM).

methodsThis population-based study included all patients who underwent minor liver resection for CRLM in the Netherlands between 2014 and 2021. Factors associated with MILR and nationwide hospital variation were assessed using multilevel multivariable logistic regression. Propensity-score matching (PSM) was applied to compare outcomes between minor MILR and minor open liver resections. Overall survival (OS) was assessed with Kaplan-Meier analysis on patients operated until 2018.

resultsOf 4,488 patients included, 1,695 (37.8%) underwent MILR. PSM resulted in 1,338 patients in each group. Implementation of MILR increased to 51.2% in 2021. Factors associated with not performing MILR included treatment with preoperative chemotherapy (aOR 0.61 CI:0.50-0.75, p < 0.001), treatment in a tertiary referral hospital (aOR 0.57 CI:0.50-0.67, p < 0.001), and larger diameter and number of CRLM. Significant hospital variation was observed in use of MILR (7.5% to 93.0%). After case-mix correction, six hospitals performed fewer, and six hospitals performed more MILRs than expected. In the PSM cohort, MILR was associated with a decrease in blood loss (aOR 0.99 CI:0.99-0.99, p < 0.01), cardiac complications (aOR 0.29, CI:0.10-0.70, p = 0.009), IC admissions (aOR 0.66, CI:0.50-0.89, p = 0.005), and shorter hospital stay (aOR CI:0.94-0.99, p < 0.01). Five-year OS rates for MILR and OLR were 53.7% versus 48.6%, p = 0.21.

conclusionAlthough uptake of MILR is increasing in the Netherlands, significant hospital variation remains. MILR benefits short-term outcomes, while overall survival is comparable to open liver surgery.

Indexed as

Colorectal NeoplasmsLaparoscopyLiver NeoplasmsHepatectomyHumansLength of StayRetrospective StudiesColorectal liver metastasesHospital variationMinimally invasive liver surgeryMinor liver resectionOverall survivalShort-term outcomes

Identifiers

PMID37072639
PMCPMC10338622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.